These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8262830)

  • 1. Management of epistaxis in Rendu-Osler disease: is brachytherapy effective?
    Pohar S; Mazeron JJ; Ghilezan M; Le Bourgeois JP; Pierquin B
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1073-7. PubMed ID: 8262830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endonasal contact radiotherapy of Rendu-Osler diseases with iridium-192].
    Pierquin B; Koskas Y; Chassagne D
    Ann Otolaryngol Chir Cervicofac; 1969 Mar; 86(3):127-31. PubMed ID: 5769826
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epistaxis in Rendu-Weber-Osler disease. The role of brachytherapy].
    Turcato G; Pizzi GB; Polico R; Antonello M; Busetto M
    Acta Otorhinolaryngol Ital; 1996 Dec; 16(6):513-6. PubMed ID: 9381921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External beam radiotherapy for severe epistaxis from Osler-Weber-Rendu disease.
    Harwood AR; Wojak JC; Barry R
    J La State Med Soc; 2002; 154(3):154-5. PubMed ID: 12139363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brachytherapy of epistaxis in Rendu-Osler disease. Indications, technic, results].
    Pizzi G; Turcato G; Polico R; Busetto M; Antonello M; Princivalli M
    Radiol Med; 1995 Jun; 89(6):861-4. PubMed ID: 7644743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [I-192 in epistaxis caused by Rendu-Osler disease].
    Gaia F
    Boll Mal Orecch Gola Naso; 1969; 87(5):410-23. PubMed ID: 5399721
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rendu-Osler disease treated by endonasal radiotherapy (evaluation of 62 cases)].
    Maylin C; Sauvage JP; Baillet F; Chassagne D; Pierquin B
    Ann Otolaryngol Chir Cervicofac; 1976; 93(1-2):95-102. PubMed ID: 970864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Vickery CL; Kuhn FA
    South Med J; 1996 Jan; 89(1):78-80. PubMed ID: 8545698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case].
    Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J
    Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease.
    Rebeiz EE; Bryan DJ; Ehrlichman RJ; Shapshay SM
    Ann Plast Surg; 1995 Aug; 35(2):208-13. PubMed ID: 7486747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment of the endonasal manifestations of Rendu-Osler disease].
    Gignoux M; Martin H; Cajgfinger H; Gignoux B; Gadot P
    J Med Lyon; 1970 Nov; 51(197):1967-8 passim. PubMed ID: 4949976
    [No Abstract]   [Full Text] [Related]  

  • 13. [Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Bergler W; Götte K; Riedel F; Back W; Hörmann K
    HNO; 1998 Mar; 46(3):228-32. PubMed ID: 9583027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osler-Rendu syndrome with fatal outcome].
    Stefaniu A; Bădescu E; Bageac C
    Otorinolaringologie; 1972; 17(6):439-43. PubMed ID: 4658227
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rendu-Osler disease: treatment with iridium 192].
    Russolo M
    Acta Otorhinolaryngol Ital; 1997 Oct; 17(5):390. PubMed ID: 9549129
    [No Abstract]   [Full Text] [Related]  

  • 17. Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with Rendu-Osler disease.
    Guldmann R; Dupret A; Nivoix Y; Schultz P; Debry C
    Laryngoscope; 2012 May; 122(5):953-5. PubMed ID: 22447341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nasal cavity dermoplasty as a treatment of recurrent bleeding in Rendu-Osler-Weber's disease].
    Kłos A; Golqbek W; Morshed K
    Otolaryngol Pol; 2007; 61(1):74-9. PubMed ID: 17605423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
    Choi JW; Joo YH; Jeong WS; Jang YJ
    Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
    Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
    Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.